{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:46a9bae9-672b-4cdd-ba5a-4a5b622c8a4d", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-30T02:45:34.738486Z", "firstcreated": "2026-10-30T02:45:16.776578Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "PET-guided treatment de-escalation keeps HER2-positive breast cancer outcomes strong at five years", "byline": "Jenna Mercer", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Science Official", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "A five-year secondary analysis of the phase 2 PHERGain trial supports a PET-guided adaptive strategy that reduces chemotherapy in HER2-positive early breast cancer, while exploratory circulating tumor DNA findings may shape future treatment decisions.", "altids": {"mosaic": "46a9bae9-672b-4cdd-ba5a-4a5b622c8a4d", "story": "ce8569d4-3be8-4cbf-8755-97917f50576f", "slug": "pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years"}, "subject": [{"name": "Health", "rel": "direct", "literal": "health", "code": "medtop:07000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/07000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "A five-year secondary analysis of the phase 2 PHERGain trial supports a PET-guided adaptive strategy that reduces chemotherapy in HER2-positive early breast cancer, while exploratory circulating tumor DNA findings may shape future treatment decisions.", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:c9cc1363-d171-40a5-b540-69b051fa361f", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial", "description_text": "PET-guided treatment de-escalation keeps HER2-positive breast cancer outcomes strong at five years", "copyrightholder": "commons.wikimedia.org", "copyrightnotice": "Jenny Mealing", "usageterms": "Open licence: the credit line must travel with the file.", "altids": {"wireva": "c9cc1363-d171-40a5-b540-69b051fa361f"}, "extra": {"wireva:delivery_mode": "file", "wireva:rights": {"licence": "CC BY 2.0", "licence_url": "https://creativecommons.org/licenses/by/2.0/", "licence_raw": "CC BY 2.0", "licence_verified_at": "2026-10-30T02:45:34.763282Z", "attribution_required": true, "attribution_text": "Jenny Mealing", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "commons.wikimedia.org", "source_url": "https://commons.wikimedia.org/wiki/File:Chemotherapy_with_acral_cooling.jpg", "source_page_url": "https://commons.wikimedia.org/wiki/File:Chemotherapy_with_acral_cooling.jpg", "our_page_url": "https://scienceofficial.org/medicine/pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years/"}, "wireva:role": "lead"}, "renditions": {"original": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/81626e715fa8894a084e0760c745f4acff068db40df96f23fbcea584f974e24e.jpg", "mimetype": "image/jpeg", "width": 675, "height": 900, "sizeinbytes": 125789}, "source": {"href": "https://commons.wikimedia.org/wiki/File:Chemotherapy_with_acral_cooling.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:ce8569d4-3be8-4cbf-8755-97917f50576f", "slug": "pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years-20261030", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Science Official", "canonical_required": true, "canonical_url": "https://scienceofficial.org/medicine/pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.737, "checked_at": "2026-10-30T02:45:34.759021Z"}}, "wireva:publication": {"name": "Science Official", "domain": "scienceofficial.org", "country": "US", "url": "https://scienceofficial.org/medicine/pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/46a9bae9-672b-4cdd-ba5a-4a5b622c8a4d", "html": "https://wireva.mib.news/item/46a9bae9-672b-4cdd-ba5a-4a5b622c8a4d/pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years/", "story": "https://wireva.mib.news/story/pet-guided-treatment-de-escalation-keeps-her2-positive-breast-cancer-outcomes-strong-at-five-years-20261030/"}, "wireva:metrics": {"word_count": 376, "char_count": 2656, "reading_time_seconds": 190}}}